# US 2012/0252010 A1 · Labelled nucleotides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252010 A1
- Document ID: US20120252010A1
- Status: Published application
- Kind: A1
- Application number: 13/437,772
- Filed: 2012-04-02
- Published: 2012-10-04
- Earliest claimed: 2001-12-04
- Assignees: Illumina Cambridge Limited
- Inventors: Shankar BALASUBRAMANIAN; Colin Barnes; Xiaohai Liu
- Web page: https://patentgrep.com/patent/US20120252010A1

## CPC

- C12Q 1/6869: Methods for sequencing
- C07H 19/10: with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H 19/20: with the saccharide radical esterified by phosphoric or polyphosphoric acids
- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C12P 19/34: Polynucleotides, e.g. nucleic acids, oligoribonucleotides
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6818: involving interaction of two or more labels, e.g. resonant energy transfer
- C12Q 1/6823: Release of bound markers
- C12Q 1/6834: Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q 2525/186: incorporating a non-extendable or blocking moiety
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}

## Abstract

Nucleosides and nucleotides are disclosed that are linked to detectable labels via a cleavable linker group.

## Claims

### Claim at position 1

1-25. (canceled)

### Claim 26

A nucleoside or nucleotide comprising a base attached to a detectable label via a cleavable linker, wherein the cleavable linker comprises a disulfide group.

### Claim 27 (depends on 26)

The nucleoside or nucleotide of claim 26, wherein the linker further comprises an azido group.

### Claim 28 (depends on 26)

The nucleoside or nucleotide of claim 26, wherein the linker further comprises a second detectable label.

### Claim 29 (depends on 26)

The nucleoside or nucleotide of claim 26, wherein the base is connected to the cleavable linker via a propargylamino or propargylamido moiety.

### Claim 30 (depends on 26)

The nucleoside or nucleotide of claim 26, wherein the base is a purine, a deazapurine, or a pyrimidine.

### Claim 31 (depends on 30)

The nucleoside or nucleotide of claim 30, wherein the base is attached to the linker at the 7-position of the purine or the 5-position of the pyrimidine.

### Claim 32 (depends on 26)

The nucleoside or nucleotide of claim 26, wherein the nucleoside or nucleotide further comprises a ribose or deoxyribose moiety.

### Claim 33 (depends on 32)

The nucleoside or nucleotide of claim 32, wherein the ribose or deoxyribose moiety comprises a hydroxyl protecting group attached to the 2′ or 3′ oxygen atom.

### Claim 34 (depends on 33)

The nucleoside or nucleotide of claim 33, wherein the same chemical conditions may be used to effect cleavage of the cleavable linker and to remove the hydroxyl protecting group.

### Claim 35 (depends on 32)

The nucleoside or nucleotide of claim 32, wherein the ribose or deoxyribose moiety comprises an unprotected 3′ hydroxyl moiety.

### Claim 36 (depends on 35)

The nucleoside or nucleotide of claim 35, wherein the detectable label has a size sufficient to prevent the incorporation of a second nucleoside or nucleotide into the ribose or deoxyribose moiety.

### Claim 37 (depends on 35)

The nucleoside or nucleotide of claim 35, wherein the cleavable linker has a size sufficient to prevent the incorporation of a second nucleoside or nucleotide into the ribose or deoxyribose moiety.

### Claim 38 (depends on 26)

The nucleoside or nucleotide of claim 26, which is a deoxyribonucleotide triphosphate.

### Claim 39 (depends on 26)

The nucleoside or nucleotide of claim 26, wherein the detectable label is a fluorophore.

### Claim 40 (depends on 1)

An oligonucleotide comprising at least one nucleotide of claim 1.

### Claim 41 (depends on 1, 40)

The oligonucleotide of claim 40, wherein at least one nucleotide of claim 1 is present at a terminal position of the oligonucleotide.

### Claim 42

A method for determining the sequence of an immobilized target polynucleotide, comprising:
(a) monitoring the sequential incorporation of nucleotides complementary to the immobilized target polynucleotide, wherein the nucleotides each have a base that is linked to a detectable label via a cleavable linker, wherein the cleavable linker comprises a disulfide group and wherein the identity of each nucleotide incorporated is determined by detection of the label linked to the base, and
(b) removing the label from the base by cleavage of the cleavable linker.

### Claim 43

A method for determining the sequence of an immobilized target polynucleotide, comprising:
(a) providing nucleotides, wherein the nucleotides have a base that is linked to a detectable label via a cleavable linker, wherein the cleavable linker comprises a disulfide group, and wherein the detectable label linked to each type of nucleotide can be distinguished upon detection from the detectable label used for other types of nucleotides;
(b) incorporating a nucleotide into the complement of the immobilized target polynucleotide;
(c) detecting the label of the nucleotide incorporated in (b), thereby determining the type of nucleotide incorporated;
(d) removing the label of the nucleotide detected in (c); and
(e) repeating steps (b)-(d) one or more times; thereby determining the sequence of a target polynucleotide.

### Claim 44 (depends on 42)

The method of claim 42, wherein non-incorporated nucleotides are removed prior to detection and subsequent to removal of the label.

### Claim 45 (depends on 42)

The method of claim 42, comprising a first step and a second step, wherein in the first step, a first composition comprising two different nucleotides is brought into contact with the target, and non-incorporated nucleotides are removed prior to detection and subsequent to removal of the label, and wherein in the second step, a second composition comprising two different nucleotides not included in the first composition is brought into contact with the target, and non-incorporated nucleotides are removed prior to detection and subsequent to removal of the label, and wherein the first step and the second step are optionally repeated one or more times.

### Claim 46 (depends on 42)

The method of claim 42, wherein four different nucleotides are supplied simultaneously.

### Claim 47 (depends on 42)

The method of claim 42, wherein the nucleotides comprise a blocking group at the 3′ position.

### Claim 48 (depends on 47)

The method of claim 47, wherein the blocking group and the label are removable using a single treatment.

### Claim 49 (depends on 42)

The method of claim 42, wherein the detectable label or the cleavable linker has a size sufficient to prevent the incorporation of a second nucleotide into the target polynucleotide.

### Claim 50 (depends on 42)

The method of claim 42, wherein the base is a pyrimidine, purine or deazapurine.

### Claim 51 (depends on 42)

The method of claim 42, wherein the nucleotides comprise a dideoxyribose moiety.

### Claim 52 (depends on 42)

The method of claim 42, wherein the label is a fluorophore.

### Claim 53 (depends on 42)

The method of claim 42, wherein the nucleotides are incorporated using a polymerase.

### Claim 54 (depends on 53)

The method of claim 53, wherein the polymerase is an engineered polymerase.
